Filter your search
Over The Counter Otc DrugsX
Kalorama Information has the data you need on the over-the-counter (OTC) pharmaceuticals market. As the pharmaceutical industry has grown, patients have become more involved in healthcare issues and have taken some medical treatment into their own hands. This has provided an opportunity for pharmaceutical companies to invest in research and development of OTC drugs. Kalorama looks at the OTC market, which includes weight loss, gastrointestinal, allergy, sleep-aid, cough, cold, and sinus drugs, among others, providing insights into pharma company strategic planning in this growing marketplace.
- $500.00 – $3,990.00Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life. Kalorama Information’s The Return of the Rx […]April 1, 2008$6,995.00 – $13,990.00Pharmaceutical marketers will face a challenging time in 2008 by all reports. Understanding the dynamics of the market can assist in better planning and strategy. This Kalorama Information Report Bundle combines 5 of the most important topics for those in the pharmaceutical industry in a strategic planning, business development or marketing. Grouped together, this report […]March 15, 2008$2,500.00 – $5,990.00Over one billion people suffer from fungal infections worldwide, and this number is growing Though Athlete’s foot, dandruff, vaginal yeast infection and fungal nail make up the bulk of these cases, there has been a steady increase in the incidence of more serious infections. This is partially due to the widespread use of antibiotics, which […]March 1, 2007$3,000.00 – $6,000.00The private label over-the-counter (OTC) market has been gaining ground rapidly over the past five years. The private label sector has shed its image of being a ‘me-too’ version of national brands and worked toward offering quality and innovation at an economical price. With benefits for consumers, retailers, and manufacturers, private label healthcare should experience […]February 1, 2006$3,000.00 – $6,000.00The U.S. Market for OTC anti-infective products surpassed the $2 billion mark last year. Although overall growth is sluggish, the market is a proven revenue source for a number of major brands, and there have been some nice surprises in the performance of some categories, such as first-aid related antiseptic and antibiotic products. This comprehensive […]January 1, 2006$3,000.00 – $6,000.00This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key […]July 1, 2005$3,000.00 – $6,000.00The U.S. market for Over-the-Counter (OTC) Pain Medication presents an in-depth analysis of the performance of various analgesics, including non-steroidal anti-inflammatory drugs (NSAID) and topical products in the US market. The analysis captures the performance of the market players, categories and leading brands in terms of revenue growth and volume growth. It also identifies key […]January 1, 2005$1,995.00 – $5,990.00The market for OTC Gastrointestinal products has gone through several significant changes in the past 5 years, most of which have to do with the Rx-to-OTC switches of two types of gastroesophageal reflux disease (GERD) drugs: H2 receptor antagonists and proton pump inhibitors (PPIs). This report on the U.S. market for OTC GI products presents […]August 1, 2004$3,500.00 – $7,000.00This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets. For this latest edition, Kalorama completely re-evaluated the market from the […]February 1, 2004$1,496.00 – $2,992.00The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others. In response to many inquiries from readers of Kalorama […]August 1, 2003